Abstract
Globalizing precision oncology should be a major priority for cancer care in the upcoming decades. In this issue, the K-MASTER study provides a framework for infrastructure building in East Asia illustrating the widening global potential of precision oncology. It is time to modify the precision oncology mantra: Give the right drug, to the right patient, at the right time in every country, to think globally and act locally.
Original language | English (US) |
---|---|
Pages (from-to) | 886-888 |
Number of pages | 3 |
Journal | Cancer discovery |
Volume | 12 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1 2022 |
ASJC Scopus subject areas
- Oncology